"The enjoyment of the highest attainable standard of health
is one of the fundamental rights of every human being without distinction of race, religion, political belief, economic or social condition".
Constitution of the World Health Organization, New York, 1946


Even 70 years after the creation of the World Health Organization, access to healthcare remains uncertain, unfair and discriminatory.

While healthcare access inequalities exist for all diseases, it is even more visible for cancer patients, who suffer from the second leading cause of death in the world.

This in turn led to the creation of Resilience.

Resilience is a safe space

Where patients and oncologists find the best information


We are developing tools to decide on a treatment and better understand the disease and its evolution

A decision support tool for oncologists to choose a treatment with a holistic approach.

An application for patients, with close monitoring and curated content to improve their quality of life.

Right from the start, a team of tech experts

We connect patients and caregivers

Raphaelle Martin-Neuville (Operations Manager), Matthieu Pozza (CPO), Lara Coudin (Administrative Manager), Jonathan Benhamou (Co-CEO), Nicolas Helleringer (CTO), Céline Lazorthes (Co-CEO).

We are hiring!

At our side, the 5th research center in the world

Resilience was co-founded with Gustave Roussy.

ln3obgxu (1).png

Gustave Roussy is the leading cancer center in Europe and the fifth best in the world. This center of expertise is dedicated to cancer patients, with nearly 50,000 patients admitted annually. The Institute is a source of therapeutic innovations and diagnostic advances, and develops an integrated approach that includes research, patient care and teaching.

Dr. Ines Vaz-Duarte-Luis, Dr. Florian Scotté, Dr. Barbara Pistilli, Dr. Fabrice André and Dr. Mikael Azoulay are coordinating the Resilience project within the hospital.

A world-renowned scientific committee

We are building the future of oncology thanks to their know-how and expertise

Fabrice André, Pr

Fabrice André is the Director of Research at Gustave Roussy. He is a world-renowned breast cancer specialist and appears in the 2019 list of the most highly cited researchers in the world.

Andre Goy, M.D., M.S

Andre Goy is an oncologist and hematologist, and serves as Chairman and Executive Director at the John Theurer Cancer Center in Hackensack, New Jersey. He also co-chairs the "Future of Health" division at the World Economic Forum in Davos.

Jean-Yves Blay, Pr

Jean-Yves Blay is an sarcoma expert who serves as Executive Director at Léon Bérard Center and is President of Unicancer. He appears in the 2019 list of most highly cited researchers in the world.

Thomas Clozel, M.D.

Thomas Clozel is a physician in clinical hematology, and was the former Clinical Director of the Public Hospitals of Paris. He is the co-founder of Owkin, a leader company in federated medical learning.

Brigitte Seroussi, M.D.

Brigitte Seroussi is an expert in clinical decision systems. She is both an engineer and an oncologist at the Tenon Hospital. She also is a Project Manager at the Delegation for Digital Health within the French Ministry of Health.


Meet the patients in our community.

Keep me posted